Back

European Journal of Neurology

20 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Incidence of SSRI treatment and psychiatric specialist care in new-onset adult epilepsy: are newer antiseizure medications associated with more treatment of anxiety/depression?
2026-02-27 neurology 10.64898/2026.02.20.26344705
#1 (5.3%)
Show abstract

BackgroundPersons with epilepsy are at increased risk of depression/anxiety. Older antiseizure medications (ASMs) had drug-drug interactions that complicated pharmacotherapy of depression/anxiety; newer ASMs lack this drawback but can have psychiatric side effects. Anxiety/depression are increasingly recognized and treated pharmacologically. We hypothesized that the likelihood of treatment with selective serotonin uptake inhibitors (SSRI) would have increased in adult-onset epilepsy when prescri...

2
Cognitive mechanisms of confabulations in Alzheimer's Disease
2026-01-30 neurology 10.64898/2026.01.30.26345197
#1 (4.6%)
Show abstract

BackgroundAlzheimers disease (AD) patients are characterized by an early decline of episodic memory due to hippocampal damage. Nonetheless, besides the classical negative symptoms related to episodic memory deficits, i.e. failure to retrieve information, it has been shown that AD patients can also suffer from positives symptoms, i.e. confabulations. Some theoretical accounts have been proposed to explain the cognitive mechanisms underlying confabulation. Yet, even if most of these models have le...

3
Cognitive assessment methods and outcomes following shunt surgery in idiopathic normal pressure hydrocephalus (iNPH): a systematic review and meta-analysis
2026-01-26 neurology 10.64898/2026.01.25.26344784
#1 (4.6%)
Show abstract

INTRODUCTIONCore cognitive deficits in iNPH include slowed information processing, psychomotor slowing and executive dysfunction. However, the cognitive benefits of iNPH treatment with shunt surgery are not well understood. This review synthesised evidence on cognitive assessment methods and outcomes following shunt surgery in iNPH. METHODSPubMed, Scopus, PsycINFO and Web of Science were searched for peer-reviewed studies including adults with iNPH who underwent shunt surgery and had within-sub...

4
Statin use and risk of amyotrophic lateral sclerosis: An active-comparator, new-user cohort study
2025-12-27 neurology 10.64898/2025.12.23.25342802
Top 0.1% (4.5%)
Show abstract

ImportanceElevated circulating low-density lipoprotein (LDL) cholesterol is associated with an increased risk of amyotrophic lateral sclerosis (ALS) onset. Previous studies have explored the relationship between statin use and ALS onset. However, findings have been inconsistent, potentially due to methodological limitations, such as confounding by indication, and failure to account for baseline differences in LDL cholesterol levels. ObjectiveTo compare the risk of ALS onset between new users of...

5
Association of Systemic Immune-Inflammation Index with Cognitive Impairment and Magnetic Resonance Imaging Markers in Patients with CADASIL
2026-01-16 neurology 10.64898/2026.01.13.26344080
Top 0.1% (4.5%)
Show abstract

BackgroundCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic hereditary cerebral small vessel disease (CSVD). Existing studies have confirmed that it is caused by mutations in the NOTCH3 gene, but the specific mechanisms underlying its pathogenesis and progression remain elusive. Existing research indicates that inflammation plays a critical role in the development and progression of CSVD. The Systemic Immune-Inflammation Index (SI...

6
Disruption of central dopamine metabolism in infants with severe spinal muscular atrophy
2026-03-02 neurology 10.64898/2026.02.28.26347004
Top 0.1% (4.2%)
Show abstract

Spinal muscular atrophy (SMA) is a severe neuromuscular disorder caused by reduced expression of the survival motor neuron (SMN) protein. In addition to affecting motor neuron survival, SMN deficiency impacts multisystem physiology and neurotransmission. Dopaminergic dysfunction has been reported in mouse models of SMA, leading to postural and locomotor impairments that improve upon treatment with L-DOPA and benserazide. However, whether altered dopamine metabolism contributes to clinical sympto...

7
Barriers and facilitators to intracerebral haemorrhage platform trial recruitment: a survey of stroke clinicians
2026-03-06 neurology 10.64898/2026.03.05.26347732
Top 0.2% (4.0%)
Show abstract

Background: Platform trials are an efficient trial design which enable testing of multiple interventions simultaneously. They could advance knowledge of treatments for intracerebral haemorrhage (ICH). We aimed to investigate the views of clinicians involved in stroke research on recruitment to a future platform trial for ICH. Methods: Between April and July 2025, we conducted a UK-wide online survey of clinicians actively involved in stroke research using convenience sampling through professiona...

8
Statistical Analysis Plan for the HOPE Trial: a randomized trial on Hemodynamic Optimization of cerebral Perfusion after Endovascular therapy in patients with acute ischemic stroke
2025-12-17 neurology 10.64898/2025.12.16.25342410
Top 0.2% (3.9%)
Show abstract

Optimal blood pressure (BP) management following endovascular treatment (EVT) for acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion remains unestablished. The randomized HOPE trial (Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke) (NCT04892511) seeks to determine if a strategy of hemodynamic optimization using different systolic BP targets, tailored to the degree of final recanalization, is sup...

9
A Novel Carotid Artery Stent System Integrating Balloon, Stent, and Embolic Protection Device Retrieval Catheter
2025-12-11 neurology 10.64898/2025.12.04.25341672
Top 0.3% (3.8%)
Show abstract

BackgroundCarotid artery stenosis is a common cause of ischemic stroke, and carotid artery stenting is an important treatment for carotid artery stenosis. However, current carotid stents face issues such as cumbersome operation procedures and frequent difficulties in retrieving embolic protection devices which can lead to complications. ObjectivesThis study evaluated the safety and efficacy of a novel carotid artery stent system which integrates balloon, stent and embolic protection device retr...

10
Improving PEG Tube Management in ALS Patients Through Educational Pamphlets
2025-12-12 neurology 10.64898/2025.12.09.25336480
Top 0.3% (3.8%)
Show abstract

Patients with amyotrophic lateral sclerosis (ALS) often experience dysphagia, leading to malnutrition and weight loss. Percutaneous endoscopic gastrostomy (PEG) tubes help address these issues, but complications and limited patient education may diminish their benefits. This project evaluated the patient experience from an educational pamphlet created by a multi-disciplinary team at our academic centers ALS Clinic. The pamphlet was distributed at the time of PEG placement and covered tube functi...

11
Association of Deep Learning-Derived Temporalis Sarcopenia with Mortality in Acute Ischemic Stroke
2026-01-23 neurology 10.64898/2026.01.21.26344571
Top 0.4% (3.6%)
Show abstract

BackgroundSarcopenia is associated with mortality and morbidity following acute ischemic stroke (AIS), but the diagnosis requires specialized equipment or time-consuming assessments. Computed tomography (CT) measures of temporal muscle volume (TMV) and density (TMD) can be opportunistically measured from existing scans and automated using deep learning (DL). This study sought to demonstrate the incremental prognostic value of DL-derived TMV and TMD from CT scans on mortality and length of stay (...

12
Real-world retention of newer antiseizure medications in children with epilepsy - a nationwide study
2026-01-16 neurology 10.64898/2026.01.15.26344172
Top 0.5% (3.6%)
Show abstract

BackgroundChildren with epilepsy are rarely included in clinical drug trials, delaying approval and introduction of new antiseizure medications (ASMs). To circumvent this we used population-wide register data to study retention, an intergrated meassure of effect and tolerability, of newer ASMs used in children in Sweden; brivaracetam, cenobamate, lacosamide, and perampanel. MethodsAll cases of incident epilepsy and subsequent ASM treatment 2007-2021 were identified using national registers. Ret...

13
Evaluation of Clinical Outcomes of Riluzole monotherapy and Riluzole based adjunctive interventions in Amyotrophic Lateral Sclerosis: A meta analytic and unsupervised clustering approach
2026-02-26 neurology 10.64898/2026.02.24.26346710
Top 0.5% (3.6%)
Show abstract

Amyotrophic Lateral Sclerosis (Lou Gehrigs disease) is a progressive neurodegenerative disease affecting hundreds of thousands of people worldwide. It is characterized by the degeneration of the neurons in the brain and spinal cord of the patients, leading to a loss of control of muscles. Over time, without nerves to stimulate them muscles tend to atrophy. ALS may occur sporadically or run in families; many mutations have been identified for the latter. Treatment of ALS is mostly limited to thre...

14
Chitinases in tear fluid of patients with Amyotrophic Lateral Sclerosis
2026-02-05 neurology 10.64898/2026.02.04.26345568
Top 0.6% (3.5%)
Show abstract

BackgroundChitinases, including chitotriosidase (CHIT1) and chitinase-3-like protein 1 (CHI3L1), are markers of neuroinflammation, a key process in amyotrophic lateral sclerosis (ALS). Tear fluid (TF) can be collected non-invasively and may represent a promising alternative to CSF or blood to study chitinases. MethodsTF was collected from 50 ALS patients and 50 control subjects using Schirmer strips. CHIT1 and CHI3L1 levels in TF, serum, and CSF were quantified using ELISA. Serum NfL was measur...

15
EARLY-ALS: A Multicentre Study on Presymptomatic and Prodromal Amyotrophic Lateral Sclerosis
2026-01-30 neurology 10.64898/2026.01.30.26345123
Top 0.6% (3.5%)
Show abstract

Neurodegenerative diseases often feature a prolonged presymptomatic phase during which pathological processes evolve before overt clinical manifestation. In Amyotrophic lateral sclerosis (ALS), defining this prodromal period is critical for identifying early disease features and the optimal window for intervention, yet it remains poorly characterised. In this cross-sectional study, we compared 475 ALS patients with 285 controls recruiting across 20 ALS expert centres in Germany and Switzerland....

16
Mechanical Thrombectomy for Medium and Distal Vessel Occlusion: A Systematic Review and Meta-Analysis
2026-01-12 neurology 10.64898/2026.01.09.26343822
Top 0.6% (3.2%)
Show abstract

ObjectiveWe aimed to do an updated meta- analysis comparing outcomes of mechanical thrombectomy (MT) associated with standard medical treatment (SMT), compared to SMT alone, in adult patients with acute ischemic stroke (AIS) due to medium or distal vessel occlusion (MDVO). MethodologyWe systematically searched PubMed, LILACS, Scielo, Cochrane, and ClinicalTrials.gov databases. Randomized controlled trials (RCTs), retrospective cohort studies, and systematic reviews with meta-analysis comparing ...

17
Asthma-like bronchodilator responsiveness in patients with neuronal intranuclear inclusion disease
2025-12-15 neurology 10.64898/2025.12.11.25342120
Top 0.7% (2.9%)
Show abstract

Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative condition characterized by the presence of intranuclear inclusions in neuronal and visceral cells. Patients with NIID can present respiratory symptoms; however, data on pulmonary functions in NIID are lacking. This study investigated the respiratory conditions in NIID patients diagnosed with histopathological and genetic studies. We conducted two spirometries before and after administrating the bronchodilator in NIID patients ...

18
Complementary Value of Transthoracic Echocardiography and Transcranial Doppler for Screening in Cryptogenic Stroke
2026-01-11 neurology 10.64898/2026.01.08.26343740
Top 0.7% (2.8%)
Show abstract

BackgroundThe optimal noninvasive screening strategy for detecting patent foramen ovale (PFO) in patients with cryptogenic stroke (CS) remains uncertain. Although transthoracic echocardiography (TTE) and transcranial Doppler (TCD) are widely used, whether combining both modalities improves diagnostic performance has not been fully established. MethodsAmong 432 consecutive CS patients, 399 underwent collaborative screening with both TTE and TCD bubble tests performed by a multidisciplinary Heart...

19
Adjunct tirofiban treatment after successful endovascular thrombectomy recanalisation in acute anterior circulation ischemic stroke (ATTRACTION): protocol of a multicenter, prospective, double-blind, randomised trial
2026-02-26 neurology 10.64898/2026.02.25.26346143
Top 0.8% (2.7%)
Show abstract

BackgroundSuccessful recanalisation without functional independence is a frequent phenomenon following endovascular thrombectomy for large vessel occlusion stroke. AimTo demonstrate safety and efficacy of adjunct tirofiban therapy after endovascular thrombectomy in patients with anterior circulation large vessel occlusion stroke achieving successful recanalization defined as modified Thrombolysis In Cerebral Infarction (mTICI) 2b-3. DesignThe study of adjunct tirofiban treatment after successf...

20
Evaluation of a serum protein signature as monitoring biomarker for Duchenne Muscular Dystrophy in a long-term clinical trial with corticosteroids
2026-01-02 neurology 10.64898/2025.12.18.25342544
Top 0.8% (2.7%)
Show abstract

ObjectiveDuchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder for which monitoring biomarkers are urgently needed. We aimed to evaluate whether proteins in serum can accurately monitor patients function within the duration of a clinical trial. MethodsIn this study, we evaluated longitudinal serum proteins of DMD patients participating to the FOR-DMD clinical trial, comparing daily and intermittent corticosteroid regimens in boys aged 4-8 years at baseline. Using the aptamer...